Financial Performance - Net sales for the year ended December 31, 2024, increased by 22.4million,or4.5516.0 million compared to 493.6millionin2023[269]−Grossprofitroseby18.1 million, or 10.0%, to 198.8millionin2024,upfrom180.7 million in 2023[269] - Income from operations increased by 17.3million,or30.773.8 million for the year ended December 31, 2024[269] - Net income for 2024 was 55.9million,reflectinga9.3 million increase, or 20.0%, from 46.6millionin2023[269]−EBITDAincreasedby8.8 million, or 15.7%, to 64.8millionfortheyearendedDecember31,2024,comparedto56.0 million for the year ended December 31, 2023[297] - Adjusted EBITDA increased by 15.9million,or23.384.1 million for the year ended December 31, 2024, from 68.2millionfortheyearendedDecember31,2023[297]SalesandVolumeGrowth−VitaCocoCoconutWaternetsalesgrewby26.1 million, or 8.2%, to 343.3millionin2024,drivenbyincreasedcaseequivalent(CE)volumeandpricingactions[275]−Totalvolumeincaseequivalent(CE)increasedby4.312.1 million, or 2.8%, to 442.3million,primarilyduetoCEvolumegrowthof2.710.3 million, or 16.3%, to 73.7millionfortheyearendedDecember31,2024,drivenbyCEvolumegrowthof12.88.5 million, or 20.3%, to 50.3 million for the year ended December 31, 2024, primarily due to higher CE volume in the European region[279] Expenses and Income - SG&A expense increased by 0.7 million, or 0.6%, to 125.0millionfortheyearendedDecember31,2024,primarilyduetoincreasedpersonnel−relatedexpenses[285]−Incometaxexpensewas14.8 million for the year ended December 31, 2024, an increase of 31.4% from 11.3millionfortheyearendedDecember31,2023[291]CashFlowandInvestments−Cashandcashequivalentsincreasedto164.7 million as of December 31, 2024, from 132.5millionasofDecember31,2023[301]−Cashprovidedbyoperatingactivitiesdecreasedby64.3 million, or 60.0%, from 107.2millionin2023to42.9 million in 2024, primarily due to increased inventory purchases and timing of working capital payments[307] - Cash used in investing activities increased by 0.4million,or64.00.6 million in 2023 to 1.0millionin2024,drivenbyequipmentpurchasesandtechnology−relatedcapitalexpenditures[308]−Netcashusedbyfinancingactivitiesincreasedby14.6 million, or 231.9%, from 6.3millionin2023to8.3 million in 2024, primarily due to share repurchases[309] - The net decrease in cash and cash equivalents was 33.1millionin2024,comparedtoanetincreaseof113.2 million in 2023, representing a change of 70.8%[305] Financial Position and Commitments - The company had no amounts drawn on the Revolving Credit Facility as of December 31, 2024, and was compliant with all financial covenants[314] - The company entered into a 60millionRevolvingCreditFacility,whichwasamendedandextendedforfiveyearsonFebruary14,2024,withamaturitydateofFebruary13,2030[311]−Thecompanyhasfutureminimumcommitmentsunderoperatingleasesamountingto0.4 million as of December 31, 2024[318] - The company has inventory purchase commitments due within one year, including raw material and packaging commitments[319] - As of December 31, 2024, the outstanding balance on vehicle loans was less than 0.1million,withinterestratesrangingfrom4.562.6 million in 2023 to 6.7millionin2024[269]−Interestincomeincreasedby4.1 million, or 160.2%, to 6.7millionfortheyearendedDecember31,2024,duetoacashinvestmentprograminitiatedinApril2023[289]−Unrealizedlossesonderivativeinstrumentsincreasedsignificantly,fromalossof872,000 in 2023 to a loss of 8.2millionin2024[269]−Thecompanyexperiencedaforeigncurrencylossof1.6 million in 2024, compared to a loss of 251,000in2023[269]−PrivateLabelnetsalesdecreasedby13.3 million, or 12.9%, to 89.9millionfortheyearendedDecember31,2024,from103.2 million for the year ended December 31, 2023[276] - There were no impairments recorded for goodwill for the years ended December 31, 2024, and 2023[331]